CN1562151A - Medicinal formulation for treating upper respiratory track infection and its design method - Google Patents
Medicinal formulation for treating upper respiratory track infection and its design method Download PDFInfo
- Publication number
- CN1562151A CN1562151A CN 200410017319 CN200410017319A CN1562151A CN 1562151 A CN1562151 A CN 1562151A CN 200410017319 CN200410017319 CN 200410017319 CN 200410017319 A CN200410017319 A CN 200410017319A CN 1562151 A CN1562151 A CN 1562151A
- Authority
- CN
- China
- Prior art keywords
- grams
- cell cube
- radix
- medicine
- rhizoma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
A Chinese medicine for treating upper respiratory tract infection is prepared from 38 Chinese-medicinal materials including mint, chrysanthemum flower, liuqorice root, cinammon twigs, etc.
Description
Technical field: the present invention relates to a kind of pharmaceutical formulation and method for designing thereof for the treatment of upper respiratory tract infection, belong to the field of Chinese medicines.
Background technology: the thinking of Chinese patent medicine research and development at present relatively concentrates on: the research method theoretical system instructs, the drug research synthesis path, and three aspects of scope are instructed in the result of study clinical practice.
The content that Chinese medicine prescription is mainly studied is: with traditional Chinese medical science scientific principle, method side's medicine principles of formulating prescriptions is guidance, adopt flavour of a drug quantity selection mode to screen little compound recipe, as the ancient prescription Styrax Pilulae, prescription medication 15 flavors, changing system into the coronary disease Styrax Pilulae is 5 flavors, and changing system into Subing drop pills is 2 flavors." Chinese herbal medicine " 2002 the 33rd volume the 7th phase: 577-580, " some thinking of modern traditional Chinese patent medicine research and development " disclose above content.Its innovative ideas is improved to the master with flavour of a drug and dosage or dosage form.
The designing technique of existing Chinese patent medicine formula is characterized as: 1, design principle: the guiding theory of using the tcm clinical practice determination of treatment based on pathogenesis obtained through differentiation of symptoms and signs.2, the method for medicine tissue: the medicine method for organizing that makes up mutually between single medicinal material and the single medicinal material.3, formulation composition pattern: the integral type pattern of single medicinal material organizational structure.4, application system: the full medicine application system of integral type.5, the scope of application: the particular disorder in the particular range.6, drug action: specific drug action.
" Chinese crude drug " 2002 the 25th the 12nd phases of volume: 918 " Lonicerae and Forsythiae Powder concentrates the preparation and the clinical practices of bagged steeping drug " disclose a kind of treatment common cold due to wind heat class medicine Lonicerae and Forsythiae Powder and have concentrated bagged steeping drug, prescription by: 30 parts of Flos Loniceraes, 30 parts of Fructus Forsythiaes, 18 parts of Radix Platycodoniss, 18 parts of Herba Menthaes, 12 parts of Herba Lophatheris, 12 parts of Herba Schizonepetae, 12 parts of Fructus Arctiis, Rhizoma Phragmitis are formed for 15 parts.By this prescription as can be seen, adopted the medicine method for organizing that makes up mutually between single medicinal material and the single medicinal material, single medicinal material organizational structure integral type formulation composition pattern.Effect: relieving the exterior syndrome with drugs of pungent in flavor and cool in nature, heat-clearing and toxic substances removing is specific drug effect.Indication: influenza or have some inkling of a cold, generate heat, cough, pharyngalgia, have a headache, be afraid of cold, thin fur from or little red, the edema number in tongue limit, be the particular disorder in the particular range.
From the drug effect basis of above pharmaceutical formulation, the clinical applicability situation analysis of application foundation, from the cause of disease of common cold due to wind heat class disease and the complexity of human body: there is different disease reflections between the different patients, some patient's anemopyretic cold heating paresthesia is lighter, and some patient is with hyperpyrexia.Assorted being accompanied by dyspepsia that some patient coughs that symptom is extra heavy, some patient holds concurrently or hold under the arm wetly, some disease belongs to deficiency syndrome, and the true card of some disease, degree has gently also to be had heavily.Multiple symptom appears in some patient simultaneously, and wherein one to two kind of disease only appears in some patient.If wind heat
The patient of type flu class uses the Lonicerae and Forsythiae Powder treatment, is as good as the phenomenon that medicine is not suited the medicine to the illness to occur, and does not have the due therapeutical effect of medicine.
The People's Health Publisher publishes, Li Dexin writes organic conception, perpetual motion idea, the determination of treatment based on pathogenesis obtained through differentiation of symptoms and signs idea that " Basic Theories of Chinese Medicine " 2001:12-22 discloses tcm clinical practice, be exactly the characteristic of analysis of disease contradiction, thereby grasp the essence of disease, carry out appropriate treatment.
Consitution difference from the human body self existence, difference to same disease reflects the different various diseases of various degree that showed, medicine effect for treating demand is within the specific limits seen, drug effect basis, the application foundation of existing Chinese patent medicine formula drug effect and the formed medicine of method for designing thereof exist range of application narrow, the unfavorable shortcoming of comprehensive therapeutic effect is applicable to that relatively the symptomatic treatment of the directly simple disease of some causes of disease is used.To the frequently-occurring disease in people's daily life, epidemic diseases, difficult disease, its particular treatment scope, specific drug action, in clinical practice, just be difficult to according to the requirement of tcm clinical practice guiding theory, at different diseases, in certain therapeutic domain, use corresponding medicine, bring into play the due therapeutical effect of drug effect, more be difficult to embody the curative effect characteristics of Chinese medicine compound.
Then there is not the shortcoming on the drug effect demand in the decoction medicine that tcm prescription provides, traces it to its cause, and the crux of problem is the drug effect basis of filling a prescription, the reason of application foundation.
Summary of the invention:
Terminological interpretation: cell cube: the single medicinal material in the Chinese medicine preparation or the compositions of several single medicinal materials also can be described as the compound recipe that folk prescription or several folk prescription are formed.
The technical issues that need to address of the present invention are: improve the subject range to same disease of the medicine of preventing and treating upper respiratory tract infection disease, improve therapeutic effect, a kind of medicine and recipe design method thereof of preventing and treating upper respiratory tract infection disease is provided.The whole drug effect of this pharmaceutical formulation has good curative effect for the specific upper respiratory tract disease of prescription, particularly Pei Fang drug effect basis, application foundation can be to the various degree in the scope of same disease different multiple upper respiratory tract infection diseases have the therapeutical effect of broad spectrum activity.The method for designing of this pharmaceutical formulation can strengthen the overall strength of drug effect, particularly can expand the range of application of drug effect, improves the therapeutic effect of drug effect, effectively solves the guiding theory disconnection problem of Chinese patent medicine drug effect basis, application foundation and tcm clinical practice diagnostic agent.Thereby reach the purpose of the health care that gets rid of illness.
Technical scheme of the present invention is: a kind of pharmaceutical formulation for the treatment of upper respiratory tract infection, it is characterized in that with the cell cube being unit, and combine the first module body by 9 cell cubes: Herba Menthae 6 grams, Flos Chrysanthemi 12 grams, Herba Eupatorii 12 grams, Rhizoma Phragmitis 18 grams, Radix Glycyrrhizae 4.5 grams; Second cell cube: Ramulus Cinnamomi 9 grams, the Radix Paeoniae Alba 9 grams, Radix Glycyrrhizae Preparata 6 grams, Rhizoma Zingiberis Recens 9 grams, Fructus Jujubae 15 grams; The 3rd cell cube: Herba Ephedrae 4.5 grams, BEIXINGREN 9 grams, Gypsum Fibrosum 24 grams, Radix Glycyrrhizae 4.5 grams; The 4th cell cube: Radix Et Rhizoma Rhei 9 grams, Rhizoma Coptidis 9 grams, Radix Scutellariae 12 grams; The 5th cell cube: Semen Raphani 6 grams, Semen Sinapis Albae 4.5 grams, Fructus Perillae 9 grams; The 6th cell cube: Radix Saposhnikoviae 9 grams, the Radix Angelicae Dahuricae 9 grams, Rhizoma Chuanxiong 6 grams; The 7th cell cube: the Radix Astragali 12 grams, Radix Codonopsis 9 grams, Poria 12 grams, the Rhizoma Atractylodis Macrocephalae 12 grams, Radix Glycyrrhizae Preparata 6 grams; The 8th cell cube: Radix Adenophorae (Radix Glehniae) 15 grams, Bulbus Fritillariae Uninbracteatae 12 grams, Fructus Momordicae 12 grams, Radix Platycodonis 9 grams, orange 4.5 grams; The 9th cell cube: Radix Isatidis 15 grams, Herba Houttuyniae 15 grams, Flos Lonicerae 12 grams, Fructus Forsythiae 12 grams, Radix Paeoniae Rubra 9 grams.
The first module body is a wind-heat-dispersing medicinal, effect: wind and heat dispersing, removing dampness for regulating stomach.Indication: anemopyretic cold from the beginning of little thirsty, the headache of, slight fever, uncomfortable in chest, throat is not well.
Second cell cube is a wind-cold-dispersing medicinal, effect: expelling pathogenic factors from muscles is delivered, harmonizing yingfen and weifen.Indication: just feel wind and cold, disharmony of nutrient QI with defensive QI, have a headache and fever, perspiration and aversion to wind, alternating episodes of chills and fever.
The 3rd cell cube is the depressed lung-energy dispersing medicine, effect: lung qi dispersing, heat clearing away, relieving asthma.Indication: accumulatiorn of pathogenic heat in the lung, cough, asthma, thirsty, irritated.
The 4th cell cube is a heat clearing and fire purging medicine, effect: eliminating fire and detoxication, clearing away heat and eliminating dampness.Indication: all fire are contained heat symptom-complex.
The 5th cell cube is the expectorant antitussive, effect: lowering the adverse-rising QI to resolve phlegm.Indication: cough with dyspnea, abundant expectoration uncomfortable in chest.
The 6th cell cube is the wind dispelling analgesic, effect: the hot-tempered wet disease of ending of wind dispelling.Indication: headache, general pain, rheumatism.
The 7th cell cube is a qi-benefiting and spleen-strengthening drug, effect: invigorating the spleen and benefiting QI.Indication: weakness of the spleen and stomach, the deficiency of vital energy are weak, decreased food intake, loose stool.
The 8th cell cube is the hot-tempered sore-throat relieving medicine of profit, effect: nourishing the lung to arrest cough, dispelling phlegm and relieving sore-throat.Indication: lung-heat is hot-tempered to be coughed, discomfort in the throat, expectorant are told not well.
The 9th cell cube is the eliminating inflammation and expelling toxin medicine, effect: heat-clearing and toxic substances removing, detumescence.Indication: cellulitis, sore, damp-heat disease, epidemic diseases, infectious disease.
Complete square nine the cell cubes combinations of adopting are for the treatment wind heat is stopped up Sheng, excess in both the exterior and interior card medicine, effect: disperse ailment said due to cold or exposure, heat-clearing and toxic substances removing, anti-inflammatory analgetic, pathogenic fire purging relieving constipation, expelling phlegm for arresting cough, replenishing QI to invigorate the spleen.Indication: excess in both the exterior and interior diseases such as the inflammation that upper respiratory tract infection disease, flu epidemic diseases cause, hyperpyrexia, expectorant heap soil or fertilizer over and around the roots, constipation.
The processing of formulation Design and product comprises following 8 aspects, and 1, design principle: instructing dialectical, perpetual motion idea to instruct opinion to control with the Chinese medicine organic conception is guiding theory; 2, application system: make tcm clinical practice and suit the remedy to the case, select mechanism with the medicinal application of disease plus-minus; 3, medicine organizational form: the medicine organizational form that mutually combines between cell cube and the cell cube, cell cube are made up of the single medicinal material in the prescription or the assembly of several single medicinal materials respectively.4, formulation composition: combinative structure between cell cube and the cell cube, the split type integrated mode of integral formula, integral formula is combined by two above cell cubes.5, the scope of application: the various disease conditions in the particular range.6, drug action: the multiple drug action in the specific drug effect scope.7, processing method: the method that adopts cell cube to process separately, synthesize, pack, conventional method is adopted in processing.8, integral product packaging structure pattern: adopt the cell cube product to pack separately, be assembled into the product structure pattern of integral product packing assembly.Can be made into diffusing, capsule, granule, bagged steeping drug type.
The invention has the beneficial effects as follows: from a kind of beneficial effect for the treatment of the pharmaceutical formulation of upper respiratory tract infection of the present invention: because drug effect basis, the application foundation of this pharmaceutical formulation are enhanced, therefore decapacitation obtains outside the good curative effect at specific upper respiratory tract infection disease, simultaneously the different multiple disease of various degree in the same diseases range is had the curative effect of broad spectrum activity.
For example the clinical suitable effect of the common cold due to wind heat class case of upper respiratory tract infection is seen: wind heat is stopped up contain, the upper respiratory tract infection disease of excess in both the exterior and interior type can be used prescription population of cells body composition of medicine, can select to use cell cube medicine with wind-heat-dispersing medicinal effect to the lighter patient of anemopyretic cold symptom, can use cell cube medicine emphatically to what suffer from the hyperpyrexia disease with antipyretic effect, increase its agent separately, the cell cube medicine of the analgesic effect used of headache, the cell cube medicine of the inflammation-diminishing and cough-controlling used of pharyngeal swelling cough, no matter be anemopyretic or wind-chill cold, deficiency syndrome or excess syndrome, being accompanied by dyspepsia is still held under the arm wet, constipation or inflammation can be according to the treatment of diseases needs, employing is suited the remedy to the case, with disease plus-minus method, select the cell cube medicine of corresponding drug effect.The existing therapeutic goal of the application foundation of drug effect is correct, the measure flexible characteristic, can overcome ill no medicine again and control, anosis blind evils of taking medicine.Can also keep simultaneously with tcm clinical practice in guiding theory, application system, drug action three coordination harmonious, supplement and complement each other, can play at many levels too many levels, the broad spectrum activity therapeutical effect of many target spots to upper respiratory tract infection disease patient.Demonstrate fully the characteristic of Chinese medicine compound comprehensive coordination and function performance.
Beneficial effect from this recipe design method:, make each cell cube in the prescription have separately characteristic drug effect respectively because this recipe design method has adopted between cell cube and the cell cube medicine method for organizing new technique of combination mutually.The formulation composition pattern of the split type combination of cell cube forms the basis of the application respectively of each cell cube, synergistic application, overall applicability.Can be in clinical application according to the guiding theory of tcm clinical practice determination of treatment based on pathogenesis obtained through differentiation of symptoms and signs, according to the needs of clinical disease treatment, bring into play the characteristic drug action of cell cube separately, the specific drug action of performance population of cells body combination that again can be whole, and can select to adopt the cell cube drug effect to make up the mode of synergistic application, make the laddering enhancing of strength of cell cube drug effect, the many-sided expansion of range of application.Thereby the drug effect basis of cell cube medicine, application foundation are complementary with the guiding theory of tcm clinical practice diagnostic agent, and it is dynamic curative effect effect that the static curative effect effect of Chinese patent medicine drug effect is promoted.
The specific embodiment:
Embodiment 1: wind heat is stopped up Sheng, excess in both the exterior and interior, is nine the cell cubes combinations in full side, the first module body: Herba Menthae 6 grams, and Flos Chrysanthemi 12 restrains, Herba Eupatorii 12 grams, Rhizoma Phragmitis 18 grams, Radix Glycyrrhizae 4.5 grams; Second cell cube: Ramulus Cinnamomi 9 grams, the Radix Paeoniae Alba 9 grams, Radix Glycyrrhizae Preparata 6 grams, Rhizoma Zingiberis Recens 9 grams, Fructus Jujubae 15 grams; The 3rd cell cube: Herba Ephedrae 4.5 grams, BEIXINGREN 9 grams, Gypsum Fibrosum 24 grams, Radix Glycyrrhizae 4.5 grams; The 4th cell cube: Radix Et Rhizoma Rhei 9 grams, Rhizoma Coptidis 9 grams, Radix Scutellariae 12 grams; The 5th cell cube: Semen Raphani 6 grams, Semen Sinapis Albae 4.5 grams, Fructus Perillae 9 grams; The 6th cell cube: Radix Saposhnikoviae 9 grams, the Radix Angelicae Dahuricae 9 grams, Rhizoma Chuanxiong 6 grams; The 7th cell cube: the Radix Astragali 12 grams, Radix Codonopsis 9 grams, Poria 12 grams, the Rhizoma Atractylodis Macrocephalae 12 grams, Radix Glycyrrhizae Preparata 6 grams; The 8th cell cube: Radix Adenophorae (Radix Glehniae) 15 grams, Bulbus Fritillariae Uninbracteatae 12 grams, Fructus Momordicae 12 grams, Radix Platycodonis 9 grams, orange 4.5 grams; The 9th cell cube: Radix Isatidis 15 grams, Herba Houttuyniae 15 grams, Flos Lonicerae 12 grams, Fructus Forsythiae 12 grams, Radix Paeoniae Rubra 9 grams.Effect: disperse ailment said due to cold or exposure, heat-clearing and toxic substances removing, anti-inflammatory analgetic, pathogenic fire purging relieving constipation, expelling phlegm for arresting cough, replenishing QI to invigorate the spleen.Indication: can be used for upper respiratory tract infection disease and change edema caused by disorder of QI battalion over to stage by stage, existing high heat cough, dry pharynx crimson tongue without fur, constipation have aversion to cold concurrently, have a headache lossless or the Wei Liangzhi of slight perspiration exterior syndrome battalion.
Usage and dosage: each cell cube crude drug is generally consumption every day in the prescription.This medicine is made and is adopted conventional preparation method.Can be made into diffusing, capsule, granule, bagged steeping drug type.Divide and take for three times, specifically look patient age size, physical strength, disease weight by treating plus-minus as one sees fit.
Embodiment 2: the control of flu epidemic diseases: for the wind heat virus type, be first module body, the 9th cell cube, the combination of the 7th cell cube, concrete proportioning is: Herba Menthae 6 grams, Flos Chrysanthemi 12 grams, Herba Eupatorii 12 grams, Rhizoma Phragmitis 18 grams, Radix Glycyrrhizae 4.5 grams, the Radix Astragali 12 grams, Radix Codonopsis 9 grams, Poria 12 grams, the Rhizoma Atractylodis Macrocephalae 12 grams, Radix Glycyrrhizae Preparata 6 grams, Radix Isatidis 15 grams, Herba Houttuyniae 15 grams, Flos Lonicerae 12 grams, Fructus Forsythiae 12 grams, Radix Paeoniae Rubra 9 grams.Effect: wind and heat dispersing, heat-clearing and toxic substances removing, replenishing QI to invigorate the spleen.The consumption usage is with reference to embodiment 1.
Embodiment 3: the control of flu epidemic diseases: for the wind and cold virus type, be second cell cube, the 9th cell cube, the combination of the 7th cell cube, concrete proportioning is: Ramulus Cinnamomi 9 grams, the Radix Paeoniae Alba 9 grams, Radix Glycyrrhizae Preparata 6 grams, Rhizoma Zingiberis Recens 9 grams, Fructus Jujubae 15 grams, Radix Isatidis 15 grams, Herba Houttuyniae 15 grams, Flos Lonicerae 12 grams, Fructus Forsythiae 12 grams, Radix Paeoniae Rubra 9 grams, the Radix Astragali 12 grams, Radix Codonopsis 9 grams, Poria 12 grams, the Rhizoma Atractylodis Macrocephalae 12 grams, Radix Glycyrrhizae Preparata 6 grams.Effect: harmonizing yingfen and weifen, heat-clearing and toxic substances removing, replenishing QI to invigorate the spleen.The consumption usage is with reference to embodiment 1.
Embodiment 4: anemopyretic cold, and the lossless asthma of thermogravimetric is first module body and the combination of the 3rd cell cube, proportioning is determined with reference to embodiment 1.The consumption usage is with reference to embodiment 1.
Embodiment 5: anemopyretic cold, and the lossless asthma of thermogravimetric, the headache nasal obstruction is first module body, the 3rd cell cube, the combination of the 6th cell cube, proportioning is determined with reference to embodiment 1.The consumption usage is with reference to embodiment 1.
Embodiment 6: anemopyretic cold, and the lossless asthma of thermogravimetric, the headache nasal obstruction, heat syndrome cough or expectorant are told not well, are first module body, the 3rd cell cube, the 6th cell cube, the combination of the 8th cell cube, and proportioning is determined with reference to embodiment 1.The consumption usage is with reference to embodiment 1.
Embodiment 7: anemopyretic cold, and the lossless asthma of thermogravimetric, the headache nasal obstruction, heat syndrome cough or expectorant are told not well, and laryngopharynx swelling and pain is first module body, the 3rd cell cube, the 6th cell cube, the 8th cell cube, the combination of the 9th cell cube, and proportioning is determined with reference to embodiment 1.The consumption usage is with reference to embodiment 1.
Embodiment 8: anemopyretic cold, the lossless asthma of thermogravimetric, headache nasal obstruction, heat syndrome cough or expectorant are told not well, laryngopharynx swelling and pain, and the deficiency of vital energy is wet is stranded, be first module body, the 3rd cell cube, the 6th cell cube, the 8th cell cube, the 9th cell cube, the combination of the 7th cell cube, proportioning is determined with reference to embodiment 1.The consumption usage is with reference to embodiment 1.
Embodiment 9: anemopyretic cold, the lossless asthma of thermogravimetric, the headache nasal obstruction, heat syndrome cough or expectorant are told not well, laryngopharynx swelling and pain, the deficiency of vital energy is wet is stranded, the heavy or constipation of expectorant, be first module body, the 3rd cell cube, the 6th cell cube, the 8th cell cube, the 9th cell cube, the 7th cell cube, the combination of the 4th cell cube, proportioning is determined with reference to embodiment 1.The consumption usage is with reference to embodiment 1.
Embodiment 10: anemofrigid cold, and the real lossless general pain of table is the combination of second cell cube and the 6th cell cube, proportioning is determined with reference to embodiment 1.The consumption usage is with reference to embodiment 1.
Embodiment 11: anemofrigid cold, and the real lossless general pain of table, cough with copious phlegm is second cell cube, the 6th cell cube, the combination of the 5th cell cube, proportioning is determined with reference to embodiment 1.The consumption usage is with reference to embodiment 1.
Embodiment 12: anemofrigid cold, and the real lossless general pain of table, cough with copious phlegm, the deficiency of vital energy is wet is stranded, and is second cell cube, the 6th cell cube, the 5th cell cube, the combination of the 7th cell cube, and proportioning is determined with reference to embodiment 1 principle.
Embodiment 13: the wind and cold heat-transformation, and laryngopharynx swelling and pain, the state of an illness transforms, and is the combination of second cell cube and the 9th cell cube, and proportioning is determined with reference to embodiment 1.The consumption usage is with reference to embodiment 1.
Embodiment 14: the wind and cold heat-transformation, and laryngopharynx swelling and pain, constipation is second cell cube, the 9th cell cube, the combination of the 4th cell cube, proportioning is determined with reference to embodiment 1.The consumption usage is with reference to embodiment 1.
Embodiment 15: the wind and cold heat-transformation, and laryngopharynx swelling and pain, constipation, the headache general pain is second cell cube, the 9th cell cube, the 4th cell cube, the combination of the 6th cell cube, proportioning is determined with reference to embodiment 1.The reference of consumption usage
Embodiment 1.
Embodiment 16: the wind and cold heat-transformation, and laryngopharynx swelling and pain, constipation, the headache general pain, interior-heat asthma is second cell cube, the 9th cell cube, the 4th cell cube, the 6th cell cube, the combination of the 3rd cell cube, proportioning is determined with reference to embodiment 1.The consumption usage is with reference to embodiment 1.
Embodiment 17: heat in the exterior and cold in the interior, be first module body and the combination of second cell cube, and proportioning is determined with reference to embodiment 1.Effect: wind and heat dispersing, harmonizing yingfen and weifen.Indication: wind heat endogenous cold type flu.The reference of consumption usage
Embodiment 1.
Embodiment 18: the exogenous cold interior-heat is the combination of second cell cube and the 3rd cell cube, and proportioning is determined with reference to embodiment 1.Effect: expelling pathogenic factors from muscles is delivered, and removes interior-heat.Indication: pattern of fever flu in the wind and cold.The reference of consumption usage
Embodiment 1.
Embodiment 19: the diseases caused by exogenous pathogenic factor cold is hot-tempered, is the combination of second cell cube and the 8th cell cube, and proportioning is determined with reference to embodiment 1.Effect: expelling pathogenic factors from muscles is delivered, and moistens hot-tempered.Indication: hot-tempered type flu in the affection due to external wind and heat.The reference of consumption usage
Embodiment 1.
Claims (2)
1, a kind of pharmaceutical formulation for the treatment of upper respiratory tract infection is characterized in that with the cell cube being unit, is combined the first module body by 9 cell cubes: Herba Menthae 6 grams, Flos Chrysanthemi 12 grams, Herba Eupatorii 12 grams, Rhizoma Phragmitis 18 grams, Radix Glycyrrhizae 4.5 grams; Second cell cube: Ramulus Cinnamomi 9 grams, the Radix Paeoniae Alba 9 grams, Radix Glycyrrhizae Preparata 6 grams, Rhizoma Zingiberis Recens 9 grams, Fructus Jujubae 15 grams; The 3rd cell cube: Herba Ephedrae 4.5 grams, BEIXINGREN 9 grams, Gypsum Fibrosum 24 grams, Radix Glycyrrhizae 4.5 grams; The 4th cell cube: Radix Et Rhizoma Rhei 9 grams, Rhizoma Coptidis 9 grams, Radix Scutellariae 12 grams; The 5th cell cube: Semen Raphani 6 grams, Semen Sinapis Albae 4.5 grams, Fructus Perillae 9 grams; The 6th cell cube: Radix Saposhnikoviae 9 grams, the Radix Angelicae Dahuricae 9 grams, Rhizoma Chuanxiong 6 grams; The 7th cell cube: the Radix Astragali 12 grams, Radix Codonopsis 9 grams, Poria 12 grams, the Rhizoma Atractylodis Macrocephalae 12 grams, Radix Glycyrrhizae Preparata 6 grams; The 8th cell cube: Radix Adenophorae (Radix Glehniae) 15 grams, Bulbus Fritillariae Uninbracteatae 12 grams, Fructus Momordicae 12 grams, Radix Platycodonis 9 grams, orange 4.5 grams; The 9th cell cube: Radix Isatidis 15 grams, Herba Houttuyniae 15 grams, Flos Lonicerae 12 grams, Fructus Forsythiae 12 grams, Radix Paeoniae Rubra 9 grams.
2, the described a kind of method for designing for the treatment of the pharmaceutical formulation of upper respiratory tract infection of claim 1, it is characterized in that, the medicine organizational form adopts the medicine organizational form that mutually combines between cell cube and the cell cube, and cell cube is made up of the single medicinal material in the prescription or the assembly of several single medicinal materials respectively.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2004100173191A CN1323673C (en) | 2004-03-30 | 2004-03-30 | Medicinal formulation for treating upper respiratory track infection and its design method |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2004100173191A CN1323673C (en) | 2004-03-30 | 2004-03-30 | Medicinal formulation for treating upper respiratory track infection and its design method |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1562151A true CN1562151A (en) | 2005-01-12 |
| CN1323673C CN1323673C (en) | 2007-07-04 |
Family
ID=34478913
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB2004100173191A Expired - Fee Related CN1323673C (en) | 2004-03-30 | 2004-03-30 | Medicinal formulation for treating upper respiratory track infection and its design method |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1323673C (en) |
Cited By (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101396466A (en) * | 2008-10-18 | 2009-04-01 | 洪国隆 | Cold medicine tea composition as medicine and food, preparation method and use thereof |
| CN100525787C (en) * | 2006-08-18 | 2009-08-12 | 山东师范大学 | Bath agent for influenza defervesce and preparing method thereof |
| CN101209322B (en) * | 2007-12-25 | 2010-08-25 | 周鑫 | 'Chuierbaoting' powder |
| CN101023996B (en) * | 2007-03-26 | 2010-09-01 | 河南仲景药业股份有限公司 | Chinese medicine for treating exogenous epidemic disease and anemopyretic cold |
| CN101007122B (en) * | 2007-01-20 | 2010-11-17 | 韩礼 | Extraction solution of traditional Chinese medicine for treating common cold and upper respiratory tract diseases and preparation method |
| CN101972338A (en) * | 2010-10-14 | 2011-02-16 | 尚德信 | Chinese medicinal preparation for treating infantile upper respiratory tract infection and preparation method thereof |
| CN101983708A (en) * | 2010-11-06 | 2011-03-09 | 赵全会 | Traditional Chinese medicine for clearing lung and eliminating phlegm |
| CN101401876B (en) * | 2008-11-10 | 2011-05-25 | 孙浩峰 | Chinese medicinal composition for treating upper respiratory tract infection |
| CN102091269A (en) * | 2011-03-05 | 2011-06-15 | 中国农业科学院兰州畜牧与兽药研究所 | Medicament for treating lead poisoning of ruminant |
| CN102283366A (en) * | 2011-06-17 | 2011-12-21 | 龚国华 | Hotpot seasoning as well as preparation method and using method thereof |
| CN102302620A (en) * | 2011-09-15 | 2012-01-04 | 上海交通大学医学院附属新华医院 | Medicament for treating respiratory system diseases and application thereof |
| CN102416098A (en) * | 2011-12-07 | 2012-04-18 | 郑丽霞 | Medicine preparation used for treating upper respiratory tract infection |
| CN101366510B (en) * | 2008-09-03 | 2012-04-25 | 李富祥 | Infusion beverage for preventing common cold |
| CN102526467A (en) * | 2012-02-15 | 2012-07-04 | 中国人民解放军第三军医大学第二附属医院 | Chinese medicinal composition for treating pulmonary fungal infection and preparation method thereof |
| CN102579731A (en) * | 2012-03-27 | 2012-07-18 | 贵州省畜牧兽医研究所 | Chinese herbal preparation for treating chronic respiratory diseases |
| CN101485822B (en) * | 2008-12-31 | 2012-07-25 | 天科仁祥技术（北京）有限责任公司 | Chinese medicine with phlegm-resolving and cough-suppressing functions and preparation method thereof |
| CN102614296A (en) * | 2012-03-27 | 2012-08-01 | 南京日升昌生物技术有限公司 | Traditional Chinese medicine composition for preventing and curing respiratory diseases of livestock and application of traditional Chinese medicine composition |
| CN102727845A (en) * | 2012-06-06 | 2012-10-17 | 崔文琴 | Hawthorn Root traditional Chinese medicinal composition for treating colds, and preparation method thereof |
| CN102960873A (en) * | 2011-09-01 | 2013-03-13 | 陕西博森生物制药股份集团有限公司 | Asthma suppressing and cough relieving healthcare mask |
| CN102961693A (en) * | 2012-12-21 | 2013-03-13 | 青岛中科润美润滑材料技术有限公司 | Composition for treating cold |
| CN103610789A (en) * | 2013-11-20 | 2014-03-05 | 安徽宝芝堂药业有限公司 | Traditional Chinese medicine composition for preventing cold |
| CN103893711A (en) * | 2012-12-28 | 2014-07-02 | 贾晓萍 | Traditional Chinese medicine for treating trachitis |
| CN104027455A (en) * | 2014-06-19 | 2014-09-10 | 哈尔滨浩拓生物科技开发有限公司 | Siraitia grosvenorii dissolved granules capable of relieving cough and reducing sputum and production method thereof |
| CN104383016A (en) * | 2014-08-15 | 2015-03-04 | 格特生物制药（天津）有限公司 | Traditional Chinese medicine oral liquid treating haemophilus parasuis disease and preparation method thereof |
| CN104644929A (en) * | 2015-02-02 | 2015-05-27 | 刘金伟 | Traditional Chinese medicine for treating wind-cold type acute tonsillitis caused by exogenous wind |
| CN104771721A (en) * | 2015-03-17 | 2015-07-15 | 吉林大学 | Drug formula for treating upper respiratory infection |
| CN104826076A (en) * | 2015-05-27 | 2015-08-12 | 苗怡文 | Traditional Chinese medicine preparation for treating cough during pregnancy and preparation method thereof |
| CN104825838A (en) * | 2015-04-26 | 2015-08-12 | 李福军 | Drug for treating acute upper respiratory infection |
| CN104840786A (en) * | 2015-05-14 | 2015-08-19 | 北京康华远景科技股份有限公司 | Medicine combination for preventing bird flu and preparation method thereof |
| CN105079728A (en) * | 2014-05-08 | 2015-11-25 | 青州市杏林春膏贴科学研究所 | Plant Chinese herbal medicine composition capable of treating exopathic hyperpyrexia and preparation technology of plant Chinese herbal medicine composition |
| CN105311322A (en) * | 2014-07-30 | 2016-02-10 | 陈立云 | Chinese herbal compound for treating chronic bronchitis |
| CN114796413A (en) * | 2022-06-27 | 2022-07-29 | 江西中医药大学 | Traditional Chinese medicine composition for preventing and treating influenza and preparation method thereof |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101342331B (en) * | 2008-09-08 | 2011-05-11 | 李娜 | Traditional Chinese medicine for treating pulmonitis and upper respiratory tract infection |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1161840A (en) * | 1996-03-19 | 1997-10-15 | 路晓康 | Medicine for making four-seasons tea for treating cold and preparation technology thereof |
-
2004
- 2004-03-30 CN CNB2004100173191A patent/CN1323673C/en not_active Expired - Fee Related
Cited By (44)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100525787C (en) * | 2006-08-18 | 2009-08-12 | 山东师范大学 | Bath agent for influenza defervesce and preparing method thereof |
| CN101007122B (en) * | 2007-01-20 | 2010-11-17 | 韩礼 | Extraction solution of traditional Chinese medicine for treating common cold and upper respiratory tract diseases and preparation method |
| CN101023996B (en) * | 2007-03-26 | 2010-09-01 | 河南仲景药业股份有限公司 | Chinese medicine for treating exogenous epidemic disease and anemopyretic cold |
| CN101209322B (en) * | 2007-12-25 | 2010-08-25 | 周鑫 | 'Chuierbaoting' powder |
| CN101366510B (en) * | 2008-09-03 | 2012-04-25 | 李富祥 | Infusion beverage for preventing common cold |
| CN101396466A (en) * | 2008-10-18 | 2009-04-01 | 洪国隆 | Cold medicine tea composition as medicine and food, preparation method and use thereof |
| CN101396466B (en) * | 2008-10-18 | 2012-10-24 | 洪国隆 | Cold medicine tea composition as medicine and food, preparation method and use thereof |
| CN101401876B (en) * | 2008-11-10 | 2011-05-25 | 孙浩峰 | Chinese medicinal composition for treating upper respiratory tract infection |
| CN101485822B (en) * | 2008-12-31 | 2012-07-25 | 天科仁祥技术（北京）有限责任公司 | Chinese medicine with phlegm-resolving and cough-suppressing functions and preparation method thereof |
| CN101972338B (en) * | 2010-10-14 | 2012-01-11 | 尚德信 | Chinese medicinal preparation for treating infantile upper respiratory tract infection and preparation method thereof |
| CN101972338A (en) * | 2010-10-14 | 2011-02-16 | 尚德信 | Chinese medicinal preparation for treating infantile upper respiratory tract infection and preparation method thereof |
| CN101983708A (en) * | 2010-11-06 | 2011-03-09 | 赵全会 | Traditional Chinese medicine for clearing lung and eliminating phlegm |
| CN102091269A (en) * | 2011-03-05 | 2011-06-15 | 中国农业科学院兰州畜牧与兽药研究所 | Medicament for treating lead poisoning of ruminant |
| CN102091269B (en) * | 2011-03-05 | 2012-08-08 | 中国农业科学院兰州畜牧与兽药研究所 | Medicament for treating lead poisoning of ruminant |
| CN102283366A (en) * | 2011-06-17 | 2011-12-21 | 龚国华 | Hotpot seasoning as well as preparation method and using method thereof |
| CN102283366B (en) * | 2011-06-17 | 2014-05-14 | 龚国华 | Hotpot seasoning as well as preparation method and using method thereof |
| CN102960873A (en) * | 2011-09-01 | 2013-03-13 | 陕西博森生物制药股份集团有限公司 | Asthma suppressing and cough relieving healthcare mask |
| CN102302620A (en) * | 2011-09-15 | 2012-01-04 | 上海交通大学医学院附属新华医院 | Medicament for treating respiratory system diseases and application thereof |
| CN102416098B (en) * | 2011-12-07 | 2014-03-26 | 郑丽霞 | Medicine preparation used for treating upper respiratory tract infection |
| CN102416098A (en) * | 2011-12-07 | 2012-04-18 | 郑丽霞 | Medicine preparation used for treating upper respiratory tract infection |
| CN102526467A (en) * | 2012-02-15 | 2012-07-04 | 中国人民解放军第三军医大学第二附属医院 | Chinese medicinal composition for treating pulmonary fungal infection and preparation method thereof |
| CN102526467B (en) * | 2012-02-15 | 2013-10-23 | 中国人民解放军第三军医大学第二附属医院 | Chinese medicinal composition for treating pulmonary fungal infection and preparation method thereof |
| CN102614296A (en) * | 2012-03-27 | 2012-08-01 | 南京日升昌生物技术有限公司 | Traditional Chinese medicine composition for preventing and curing respiratory diseases of livestock and application of traditional Chinese medicine composition |
| CN102579731A (en) * | 2012-03-27 | 2012-07-18 | 贵州省畜牧兽医研究所 | Chinese herbal preparation for treating chronic respiratory diseases |
| CN102579731B (en) * | 2012-03-27 | 2013-07-03 | 贵州省畜牧兽医研究所 | Chinese herbal preparation for treating chronic respiratory diseases |
| CN102614296B (en) * | 2012-03-27 | 2013-11-06 | 南京日升昌生物技术有限公司 | Traditional Chinese medicine composition for preventing and curing respiratory diseases of livestock and application of traditional Chinese medicine composition |
| CN102727845A (en) * | 2012-06-06 | 2012-10-17 | 崔文琴 | Hawthorn Root traditional Chinese medicinal composition for treating colds, and preparation method thereof |
| CN102727845B (en) * | 2012-06-06 | 2013-11-06 | 崔文琴 | Hawthorn Root traditional Chinese medicinal composition for treating colds, and preparation method thereof |
| CN102961693A (en) * | 2012-12-21 | 2013-03-13 | 青岛中科润美润滑材料技术有限公司 | Composition for treating cold |
| CN103893711A (en) * | 2012-12-28 | 2014-07-02 | 贾晓萍 | Traditional Chinese medicine for treating trachitis |
| CN103610789A (en) * | 2013-11-20 | 2014-03-05 | 安徽宝芝堂药业有限公司 | Traditional Chinese medicine composition for preventing cold |
| CN105079728A (en) * | 2014-05-08 | 2015-11-25 | 青州市杏林春膏贴科学研究所 | Plant Chinese herbal medicine composition capable of treating exopathic hyperpyrexia and preparation technology of plant Chinese herbal medicine composition |
| CN104027455A (en) * | 2014-06-19 | 2014-09-10 | 哈尔滨浩拓生物科技开发有限公司 | Siraitia grosvenorii dissolved granules capable of relieving cough and reducing sputum and production method thereof |
| CN105311322A (en) * | 2014-07-30 | 2016-02-10 | 陈立云 | Chinese herbal compound for treating chronic bronchitis |
| CN104383016A (en) * | 2014-08-15 | 2015-03-04 | 格特生物制药（天津）有限公司 | Traditional Chinese medicine oral liquid treating haemophilus parasuis disease and preparation method thereof |
| CN104644929A (en) * | 2015-02-02 | 2015-05-27 | 刘金伟 | Traditional Chinese medicine for treating wind-cold type acute tonsillitis caused by exogenous wind |
| CN104644929B (en) * | 2015-02-02 | 2018-09-28 | 鹿洪艳 | Traditional Chinese medicine for treating wind-cold type acute tonsillitis caused by exogenous wind |
| CN104771721A (en) * | 2015-03-17 | 2015-07-15 | 吉林大学 | Drug formula for treating upper respiratory infection |
| CN104825838A (en) * | 2015-04-26 | 2015-08-12 | 李福军 | Drug for treating acute upper respiratory infection |
| CN104825838B (en) * | 2015-04-26 | 2016-03-02 | 付蔷 | A kind of medicine for the treatment of acute upper respiratory tract infection |
| CN104840786A (en) * | 2015-05-14 | 2015-08-19 | 北京康华远景科技股份有限公司 | Medicine combination for preventing bird flu and preparation method thereof |
| CN104840786B (en) * | 2015-05-14 | 2019-02-15 | 北京康华远景科技股份有限公司 | A kind of pharmaceutical composition and preparation method thereof of pre- avian influenza-prevention |
| CN104826076A (en) * | 2015-05-27 | 2015-08-12 | 苗怡文 | Traditional Chinese medicine preparation for treating cough during pregnancy and preparation method thereof |
| CN114796413A (en) * | 2022-06-27 | 2022-07-29 | 江西中医药大学 | Traditional Chinese medicine composition for preventing and treating influenza and preparation method thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1323673C (en) | 2007-07-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1323673C (en) | Medicinal formulation for treating upper respiratory track infection and its design method | |
| CN101972338B (en) | Chinese medicinal preparation for treating infantile upper respiratory tract infection and preparation method thereof | |
| CN101342317A (en) | Medicament composition for treating tuberculosis and preparation method thereof | |
| CN1486740A (en) | Chinese medicine composition for treating cancer | |
| CN102091250B (en) | Traditional Chinese medicine for treating acute tonsillitis | |
| CN101229290A (en) | Chinese traditional medicine compounds for treating common cold and throat irritation, and preparing method thereof | |
| CN102078525A (en) | Medicine combination for treating wind-heat type common cold | |
| CN102784339B (en) | Medicament for treating pulmonary tuberculosis by combined chemotherapy with traditional Chinese medicine Fuying and preparation method | |
| CN1150927C (en) | Stomatopathy and throat disease treating health care medicine and its production process | |
| CN101757206A (en) | Chinese medicine preparation for treating chronic colitis | |
| CN1060368C (en) | Traditional Chinese medicine Jinjiangkebao for treating cough | |
| CN104524537A (en) | Pharmaceutical composition for treating chronic enteritis | |
| CN103272159A (en) | Chinese herbal preparation used for treating consumptive disease and preparation method thereof | |
| CN102526488B (en) | Traditional Chinese medicine composition with pharynx-cleaning effect | |
| CN100998690A (en) | Traditional Chinese medicine detoxification preparation and its preparing method | |
| CN101708286A (en) | Chinese patent medicament for treating sjogren's syndrome and intractable oral ulcer, and preparation method thereof | |
| CN105963501A (en) | Method for preparing traditional Chinese medicine composition for treating infantile asthma | |
| CN104825626A (en) | Medicine for treating frontal sinusitis | |
| CN100411672C (en) | A medicinal composition for treatment of psoriasis | |
| CN104173830A (en) | Medicament for reconciling interior syndromes and relieving exterior syndromes for high fever of cold in winter and preparation method thereof | |
| CN1274360C (en) | Antiphlogistic and antitussive medicine powder | |
| CN100457177C (en) | Chinese medicinal health-care preparation for cloaring lung, supplementing kidney | |
| CN1219537C (en) | Chinese medicine for treating leucocythemia and its preparation method and application. | |
| CN1669569A (en) | Medicine for dispelling tinea | |
| CN105477430A (en) | Traditional Chinese medicine preparation containing folium artemisiae argyi for preventing and/or treating infantile repeated colds |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20070704 Termination date: 20110330 |